HGBCL

Clinical trials for HGBCL explained in plain language.

Never miss a new study

Get alerted when new HGBCL trials appear

Sign up with your email to follow new studies for HGBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough lymphomas: experimental drug MDX2003 enters human trials

Disease control Recruiting now

This study tests a new drug called MDX2003 in adults with several types of B-cell lymphoma (like DLBCL or follicular lymphoma) that have returned or stopped responding to at least two prior treatments. The main goals are to find the safest dose and check if the drug can shrink tu…

Matched conditions: HGBCL

Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control

Last updated May 26, 2026 11:46 UTC

HGBCL

Get alerted when new HGBCL trials appear

New hope for tough lymphomas: experimental drug MDX2003 enters human trials